Risk factors

Cardio Diagnostics Holdings (CDIO) risk factors

Item 1A of every Cardio Diagnostics Holdings, Inc. 10-K on file, and what changed from one year to the next.

Open CDIO in Gloomberb →
  • FY2025 10-K risk factors

    64 risks, 2 new, 5 dropped, 6 reworded since the prior year. Revenue dropped to $14,825 in 2025 with net losses of $6,498,167 and an accumulated deficit of $29,250,000.

    Filed Mar 13, 2026
  • FY2024 10-K risk factors

    67 risks. Cardio Diagnostics is a pre-revenue medical diagnostics company relying heavily on external financing and key university-licensed intellectual property. The company faces severe operational, competitive, and regulatory risks in the unproven epigenetic and cardiovascular testing markets.

    Filed Mar 20, 2025